NCT03574402 2022-12-06
TRUMP
Guangdong Association of Clinical Trials
Phase 2 Unknown
Clinical Trials
8 trialsNCT02330367 2021-09-10
Safety, Pharmacokinetic and Preliminary Efficacy Study of AC0010 in Patients With EGFR T790M Positive NSCLC
Hangzhou ACEA Pharmaceutical Research Co., Ltd.
Phase 1/2 Unknown
NCT02448251 2019-10-29
Safety, Pharmacokinetic and Preliminary Efficacy Study of AC0010MA in Advanced Non Small Cell Lung Cancer
ACEA Therapeutics, Inc.
Phase 1 Terminated
NCT03856697 2019-02-27
Abivertinib Maleate Versus Geifitinib in Patients With Advanced Non-small Cell Lung Cancer With Sensitive EGFR Mutation
Hangzhou ACEA Pharmaceutical Research Co., Ltd.
Phase 3 Unknown
NCT03300115 2019-02-19
Clinical Trial of the Efficacy and Safety of AC0010 in the Treatment of EGFR T790M Patients With Advanded NSCLC
Hangzhou ACEA Pharmaceutical Research Co., Ltd.
Phase 2 Unknown
NCT03053219 2019-02-01
Preliminary Evaluation of Safety and Efficacy by [14C] AC0010 Trail and Subsequent AC0010 Treatment
Hangzhou ACEA Pharmaceutical Research Co., Ltd.
Phase 1 Completed
NCT03001609 2017-10-03
Study to Investigate the Absorption, Metabolism and Excretion of [14C] AC0010 in Patients With Advanced NSCLC
Hangzhou ACEA Pharmaceutical Research Co., Ltd.
Phase 1 Completed
NCT02274337 2016-11-23
Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of AC0010 in Advanced Non Small Cell Lung Cancer
Sun Yat-sen University
Phase 1/2 Unknown